TY - STD TI - Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N Engl J Med. 2018;NEJMoa1809615. ID - ref1 ER - TY - JOUR AU - Emens, L. e. i. s. h. a. A. AU - Cruz, C. r. i. s. t. i. n. a. AU - Eder, J. o. s. e. p. h. P. a. u. l. AU - Braiteh, F. a. d. i. AU - Chung, C. a. t. h. i. e. AU - Tolaney, S. a. r. a. M. AU - Kuter, I. r. e. n. e. AU - Nanda, R. i. t. a. AU - Cassier, P. h. i. l. i. p. p. e. A. AU - Delord, J. e. a. n. -. P. i. e. r. r. e. AU - Gordon, M. i. c. h. a. e. l. S. AU - ElGabry, E. h. a. b. AU - Chang, C. h. i. n. g. -. W. e. i. AU - Sarkar, I. n. d. r. a. n. i. AU - Grossman, W. i. l. l. i. a. m. AU - O’Hear, C. a. r. o. l. AU - Fassò, M. a. r. c. e. l. l. a. AU - Molinero, L. u. c. i. a. n. a. AU - Schmid, P. e. t. e. r. PY - 2019 DA - 2019// TI - Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer JO - JAMA Oncology VL - 5 UR - https://doi.org/10.1001/jamaoncol.2018.4224 DO - 10.1001/jamaoncol.2018.4224 ID - Emens2019 ER - TY - JOUR AU - Savas, P. AU - Virassamy, B. AU - Ye, C. AU - Salim, A. AU - Mintoff, C. P. AU - Caramia, F. PY - 2018 DA - 2018// TI - Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0078-7 DO - 10.1038/s41591-018-0078-7 ID - Savas2018 ER - TY - JOUR AU - Loi, S. AU - Drubay, D. AU - Adams, S. AU - Pruneri, G. AU - Francis, P. A. AU - Lacroix-Triki, M. PY - 2019 DA - 2019// TI - Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers JO - J Clin Oncol VL - 16 ID - Loi2019 ER - TY - STD TI - Ali HR, Chlon L, Pharoah PDP, Markowetz F, Caldas C. Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study. Ladanyi M, editor. PLOS Med. 2016;13(12):e1002194. ID - ref5 ER - TY - JOUR AU - Teschendorff, A. E. AU - Miremadi, A. AU - Pinder, S. E. AU - Ellis, I. O. AU - Caldas, C. PY - 2007 DA - 2007// TI - An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer JO - Genome Biol VL - 8 UR - https://doi.org/10.1186/gb-2007-8-8-r157 DO - 10.1186/gb-2007-8-8-r157 ID - Teschendorff2007 ER - TY - JOUR AU - Desmedt, C. AU - Haibe-Kains, B. AU - Wirapati, P. AU - Buyse, M. AU - Larsimont, D. AU - Bontempi, G. PY - 2008 DA - 2008// TI - Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4756 DO - 10.1158/1078-0432.CCR-07-4756 ID - Desmedt2008 ER - TY - JOUR AU - Ignatiadis, M. AU - Singhal, S. K. S. K. AU - Desmedt, C. AU - Haibe-Kains, B. AU - Criscitiello, C. AU - Andre, F. PY - 2012 DA - 2012// TI - Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.5624 DO - 10.1200/JCO.2011.39.5624 ID - Ignatiadis2012 ER - TY - JOUR AU - Solinas, C. AU - Gombos, A. AU - Latifyan, S. AU - Piccart-Gebhart, M. AU - Kok, M. AU - Buisseret, L. PY - 2017 DA - 2017// TI - Targeting immune checkpoints in breast cancer: an update of early results JO - ESMO Open VL - 2 UR - https://doi.org/10.1136/esmoopen-2017-000255 DO - 10.1136/esmoopen-2017-000255 ID - Solinas2017 ER - TY - JOUR AU - Denkert, C. AU - Minckwitz, G. AU - Darb-Esfahani, S. AU - Lederer, B. AU - Heppner, B. I. AU - Weber, K. E. PY - 2018 DA - 2018// TI - Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(17)30904-X DO - 10.1016/S1470-2045(17)30904-X ID - Denkert2018 ER - TY - JOUR AU - Dieci, M. V. AU - Conte, P. AU - Bisagni, G. AU - Brandes, A. A. AU - Frassoldati, A. AU - Cavanna, L. AU - Musolino, A. AU - Giotta, F. AU - Rimanti, A. AU - Garrone, O. AU - Bertone, E. AU - Cagossi, K. AU - Sarti, S. AU - Ferro, A. AU - Piacentini, F. AU - Maiorana, A. AU - Orvieto, E. AU - Sanders, M. AU - Miglietta, F. AU - Balduzzi, S. AU - D’Amico, R. AU - Guarneri, V. PY - 2019 DA - 2019// TI - Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer JO - Annals of Oncology VL - 30 UR - https://doi.org/10.1093/annonc/mdz007 DO - 10.1093/annonc/mdz007 ID - Dieci2019 ER - TY - STD TI - Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: part 1: assessing the host immune response, TILs in Invasi. Adv Anat Pathol. 2017;24(5):235-51. ID - ref12 ER - TY - JOUR AU - Salgado, R. AU - Denkert, C. AU - Demaria, S. AU - Sirtaine, N. AU - Klauschen, F. AU - Pruneri, G. PY - 2014 DA - 2014// TI - The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdu450 DO - 10.1093/annonc/mdu450 ID - Salgado2014 ER - TY - JOUR AU - Finotello, F. AU - Trajanoski, Z. PY - 2018 DA - 2018// TI - Quantifying tumor-infiltrating immune cells from transcriptomics data JO - Cancer Immunol Immunother VL - 67 UR - https://doi.org/10.1007/s00262-018-2150-z DO - 10.1007/s00262-018-2150-z ID - Finotello2018 ER - TY - JOUR AU - Nik-Zainal, S. AU - Davies, H. AU - Staaf, J. AU - Ramakrishna, M. AU - Glodzik, D. AU - Zou, X. PY - 2016 DA - 2016// TI - Landscape of somatic mutations in 560 breast cancer whole-genome sequences JO - Nature. VL - 534 UR - https://doi.org/10.1038/nature17676 DO - 10.1038/nature17676 ID - Nik-Zainal2016 ER - TY - STD TI - Smid M, Rodríguez-González FGG, Sieuwerts AMAM, Salgado R, Prager-Van Der Smissen WJCWJC, Vlugt-Daane MVDM van der, et al. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nat Commun. 2016;7:12910. ID - ref16 ER - TY - JOUR AU - Brinkman, A. B. AU - Nik-Zainal, S. AU - Simmer, F. AU - Rodríguez-González, F. G. AU - Smid, M. AU - Alexandrov, L. B. PY - 2019 DA - 2019// TI - Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation JO - Nat Commun VL - 10 UR - https://doi.org/10.1038/s41467-019-09828-0 DO - 10.1038/s41467-019-09828-0 ID - Brinkman2019 ER - TY - STD TI - Park JH, Jonas SF, Bataillon G, Criscitiello C, Salgado R, Loi S, et al. Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy. Ann Oncol Off J Eur Soc Med Oncol. 2019. ID - ref18 ER - TY - STD TI - www.slidescore.com. UR - http://www.slidescore.com ID - ref19 ER - TY - JOUR AU - Newman, A. M. AU - Liu, C. L. AU - Green, M. R. AU - Gentles, A. J. AU - Feng, W. AU - Xu, Y. PY - 2015 DA - 2015// TI - Robust enumeration of cell subsets from tissue expression profiles JO - Nat Methods VL - 12 UR - https://doi.org/10.1038/nmeth.3337 DO - 10.1038/nmeth.3337 ID - Newman2015 ER - TY - STD TI - Finotello F, Mayer C, Plattner C, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11:34. https://doi.org/10.1186/s13073-019-0638-6. ID - ref21 ER - TY - JOUR AU - Becht, E. AU - Giraldo, N. A. AU - Lacroix, L. AU - Buttard, B. AU - Elarouci, N. AU - Petitprez, F. PY - 2016 DA - 2016// TI - Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression JO - Genome Biol VL - 17 UR - https://doi.org/10.1186/s13059-016-1070-5 DO - 10.1186/s13059-016-1070-5 ID - Becht2016 ER - TY - JOUR AU - Aran, D. AU - Hu, Z. AU - Butte, A. J. PY - 2017 DA - 2017// TI - xCell: digitally portraying the tissue cellular heterogeneity landscape JO - Genome Biol VL - 18 UR - https://doi.org/10.1186/s13059-017-1349-1 DO - 10.1186/s13059-017-1349-1 ID - Aran2017 ER - TY - STD TI - Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6. ID - ref24 ER - TY - JOUR AU - Chakravarthy, A. AU - Furness, A. AU - Joshi, K. AU - Ghorani, E. AU - Ford, K. AU - Ward, M. J. PY - 2018 DA - 2018// TI - Pan-cancer deconvolution of tumour composition using DNA methylation JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-05570-1 DO - 10.1038/s41467-018-05570-1 ID - Chakravarthy2018 ER - TY - JOUR AU - Massink, M. P. G. AU - Kooi, I. E. AU - Martens, J. W. M. AU - Waisfisz, Q. AU - Meijers-Heijboer, H. PY - 2015 DA - 2015// TI - Genomic profiling of CHEK2*1100delC-mutated breast carcinomas JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1880-y DO - 10.1186/s12885-015-1880-y ID - Massink2015 ER - TY - JOUR AU - Jeschke, J. AU - Bizet, M. AU - Desmedt, C. AU - Calonne, E. AU - Dedeurwaerder, S. AU - Garaud, S. PY - 2017 DA - 2017// TI - DNA methylation-based immune response signature improves patient diagnosis in multiple cancers JO - J Clin Invest VL - 127 UR - https://doi.org/10.1172/JCI91095 DO - 10.1172/JCI91095 ID - Jeschke2017 ER - TY - JOUR AU - Davoli, T. AU - Uno, H. AU - Wooten, E. C. AU - Elledge, S. J. PY - 2017 DA - 2017// TI - Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy JO - Science (80- ) VL - 355 UR - https://doi.org/10.1126/science.aaf8399 DO - 10.1126/science.aaf8399 ID - Davoli2017 ER - TY - JOUR AU - Danaher, P. AU - Warren, S. AU - Dennis, L. AU - D’Amico, L. AU - White, A. AU - Disis, M. L. PY - 2017 DA - 2017// TI - Gene expression markers of tumor infiltrating leukocytes JO - J Immunother Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0215-8 DO - 10.1186/s40425-017-0215-8 ID - Danaher2017 ER - TY - JOUR AU - Sturm, G. r. e. g. o. r. AU - Finotello, F. r. a. n. c. e. s. c. a. AU - Petitprez, F. l. o. r. e. n. t. AU - Zhang, J. i. t. a. o. D. a. v. i. d. AU - Baumbach, J. a. n. AU - Fridman, W. o. l. f. H. AU - List, M. a. r. k. u. s. AU - Aneichyk, T. a. t. s. i. a. n. a. PY - 2019 DA - 2019// TI - Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology JO - Bioinformatics VL - 35 UR - https://doi.org/10.1093/bioinformatics/btz363 DO - 10.1093/bioinformatics/btz363 ID - Sturm2019 ER - TY - JOUR AU - Rooney, M. S. AU - Shukla, S. A. AU - Wu, C. J. AU - Getz, G. AU - Hacohen, N. PY - 2015 DA - 2015// TI - Molecular and genetic properties of tumors associated with local immune cytolytic activity JO - Cell. VL - 160 UR - https://doi.org/10.1016/j.cell.2014.12.033 DO - 10.1016/j.cell.2014.12.033 ID - Rooney2015 ER - TY - JOUR AU - Ayers, M. AU - Lunceford, J. AU - Nebozhyn, M. AU - Murphy, E. AU - Loboda, A. AU - Kaufman, D. R. PY - 2017 DA - 2017// TI - IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade JO - J Clin Invest VL - 127 UR - https://doi.org/10.1172/JCI91190 DO - 10.1172/JCI91190 ID - Ayers2017 ER - TY - BOOK AU - Lin, L. a. w. r. e. n. c. e. AU - Hedayat, A. S. AU - Wu, W. e. n. t. i. n. g. PY - 2012 DA - 2012// TI - Statistical Tools for Measuring Agreement PB - Springer New York CY - New York, NY UR - https://doi.org/10.1007/978-1-4614-0562-7 DO - 10.1007/978-1-4614-0562-7 ID - Lin2012 ER - TY - BOOK AU - Douglas, G. PY - 1991 DA - 1991// TI - Altman practical statistics for medical research ID - Douglas1991 ER - TY - JOUR AU - Buisseret, L. a. u. r. e. n. c. e. AU - Desmedt, C. h. r. i. s. t. i. n. e. AU - Garaud, S. o. i. z. i. c. AU - Fornili, M. a. r. c. o. AU - Wang, X. i. a. o. x. i. a. o. AU - Van den Eyden, G. e. r. t. AU - de Wind, A. l. e. x. a. n. d. r. e. AU - Duquenne, S. e. b. a. s. t. i. e. n. AU - Boisson, A. n. a. i. s. AU - Naveaux, C. e. l. i. n. e. AU - Rothé, F. r. a. n. c. o. i. s. e. AU - Rorive, S. a. n. d. r. i. n. e. AU - Decaestecker, C. h. r. i. s. t. i. n. e. AU - Larsimont, D. e. n. i. s. AU - Piccart-Gebhart, M. a. r. t. i. n. e. AU - Biganzoli, E. l. i. a. AU - Sotiriou, C. h. r. i. s. t. o. s. AU - Willard-Gallo, K. a. r. e. n. PY - 2017 DA - 2017// TI - Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer JO - Modern Pathology VL - 30 UR - https://doi.org/10.1038/modpathol.2017.43 DO - 10.1038/modpathol.2017.43 ID - Buisseret2017 ER - TY - JOUR AU - Khoury, T. AU - Peng, X. AU - Yan, L. AU - Wang, D. AU - Nagrale, V. PY - 2018 DA - 2018// TI - Tumor-infiltrating lymphocytes in breast cancer JO - Am J Clin Pathol VL - 150 UR - https://doi.org/10.1093/ajcp/aqy069 DO - 10.1093/ajcp/aqy069 ID - Khoury2018 ER - TY - JOUR AU - Swisher, S. K. AU - Wu, Y. AU - Castaneda, C. A. AU - Lyons, G. R. AU - Yang, F. AU - Tapia, C. PY - 2016 DA - 2016// TI - Interobserver agreement between pathologists assessing tumor-infiltrating lymphocytes (TILs) in breast cancer using methodology proposed by the international TILs working group JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-016-5173-8 DO - 10.1245/s10434-016-5173-8 ID - Swisher2016 ER - TY - JOUR AU - O’Loughlin, M. AU - Andreu, X. AU - Bianchi, S. AU - Chemielik, E. AU - Cordoba, A. AU - Cserni, G. PY - 2018 DA - 2018// TI - Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study JO - Breast Cancer Res Treat VL - 171 UR - https://doi.org/10.1007/s10549-018-4825-8 DO - 10.1007/s10549-018-4825-8 ID - O’Loughlin2018 ER - TY - JOUR AU - Tramm, T. AU - Caterino, T. AU - Jylling, A. -. M. B. AU - Lelkaitis, G. AU - Lænkholm, A. -. V. AU - Ragó, P. PY - 2018 DA - 2018// TI - Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists JO - Acta Oncol (Madr) VL - 57 UR - https://doi.org/10.1080/0284186X.2017.1403040 DO - 10.1080/0284186X.2017.1403040 ID - Tramm2018 ER - TY - STD TI - Chen Z, Chen X, Zhou E, Chen G, Qian K, Wu X, et al. Intratumoral CD8+ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancer. Filleur S, editor. PLoS One. 2014;9(4):e95475. ID - ref40 ER - TY - JOUR AU - Catacchio, I. AU - Silvestris, N. AU - Scarpi, E. AU - Schirosi, L. AU - Scattone, A. AU - Mangia, A. PY - 2019 DA - 2019// TI - Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients JO - Transl Oncol VL - 12 UR - https://doi.org/10.1016/j.tranon.2018.12.005 DO - 10.1016/j.tranon.2018.12.005 ID - Catacchio2019 ER - TY - JOUR AU - Catacchio, I. AU - Scattone, A. AU - Silvestris, N. AU - Mangia, A. PY - 2018 DA - 2018// TI - Immune prophets of lung cancer: the prognostic and predictive landscape of cellular and molecular immune markers JO - Transl Oncol VL - 11 UR - https://doi.org/10.1016/j.tranon.2018.04.006 DO - 10.1016/j.tranon.2018.04.006 ID - Catacchio2018 ER - TY - JOUR AU - Galon, J. AU - Costes, A. AU - Sanchez-Cabo, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Lagorce-Pagès, C. PY - 2006 DA - 2006// TI - Type, density, and location of immune cells within human colorectal tumors predict clinical outcome JO - Science (80- ) VL - 313 UR - https://doi.org/10.1126/science.1129139 DO - 10.1126/science.1129139 ID - Galon2006 ER - TY - JOUR AU - Zhang, L. AU - Conejo-Garcia, J. R. AU - Katsaros, D. AU - Gimotty, P. A. AU - Massobrio, M. AU - Regnani, G. PY - 2003 DA - 2003// TI - Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa020177 DO - 10.1056/NEJMoa020177 ID - Zhang2003 ER - TY - JOUR AU - Rosenthal, R. AU - Cadieux, E. L. AU - Salgado, R. AU - Bakir, M. AU - Moore, D. A. AU - Hiley, C. T. PY - 2019 DA - 2019// TI - Neoantigen-directed immune escape in lung cancer evolution JO - Nature. VL - 567 UR - https://doi.org/10.1038/s41586-019-1032-7 DO - 10.1038/s41586-019-1032-7 ID - Rosenthal2019 ER - TY - JOUR AU - Sobral-Leite, M. AU - Salomon, I. AU - Opdam, M. AU - Kruger, D. T. AU - Beelen, K. J. AU - Noort, V. PY - 2019 DA - 2019// TI - Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes JO - Breast Cancer Res VL - 21 UR - https://doi.org/10.1186/s13058-019-1176-2 DO - 10.1186/s13058-019-1176-2 ID - Sobral-Leite2019 ER - TY - JOUR AU - Kurozumi, S. AU - Matsumoto, H. AU - Kurosumi, M. AU - Inoue, K. AU - Fujii, T. AU - Horiguchi, J. PY - 2019 DA - 2019// TI - Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis JO - Oncol Lett VL - 17 ID - Kurozumi2019 ER - TY - JOUR AU - Ståhl, P. L. AU - Salmén, F. AU - Vickovic, S. AU - Lundmark, A. AU - Navarro, J. F. AU - Magnusson, J. PY - 2016 DA - 2016// TI - Visualization and analysis of gene expression in tissue sections by spatial transcriptomics JO - Science. VL - 353 UR - https://doi.org/10.1126/science.aaf2403 DO - 10.1126/science.aaf2403 ID - Ståhl2016 ER - TY - JOUR AU - Crosetto, N. AU - Bienko, M. AU - Oudenaarden, A. PY - 2015 DA - 2015// TI - Spatially resolved transcriptomics and beyond JO - Nat Rev Genet VL - 16 UR - https://doi.org/10.1038/nrg3832 DO - 10.1038/nrg3832 ID - Crosetto2015 ER - TY - JOUR AU - Kündig, P. AU - Giesen, C. AU - Jackson, H. AU - Bodenmiller, B. AU - Papassotirolopus, B. AU - Freiberger, S. N. PY - 2018 DA - 2018// TI - Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer JO - J Transl Med VL - 16 UR - https://doi.org/10.1186/s12967-018-1495-6 DO - 10.1186/s12967-018-1495-6 ID - Kündig2018 ER - TY - STD TI - Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Andersen J, et al. Acta Oncologica Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. 2009; ID - ref51 ER - TY - JOUR AU - Khouja, M. H. AU - Baekelandt, M. AU - Sarab, A. AU - Nesland, J. M. AU - Holm, R. PY - 2010 DA - 2010// TI - Limitations of tissue microarrays compared with whole tissue sections in survival analysis JO - Oncol Lett VL - 1 UR - https://doi.org/10.3892/ol_00000145 DO - 10.3892/ol_00000145 ID - Khouja2010 ER - TY - JOUR AU - Camp, R. L. AU - Charette, L. A. AU - Rimm, D. L. PY - 2000 DA - 2000// TI - Validation of tissue microarray technology in breast carcinoma JO - Lab Investig VL - 80 UR - https://doi.org/10.1038/labinvest.3780204 DO - 10.1038/labinvest.3780204 ID - Camp2000 ER - TY - JOUR AU - Gruosso, T. AU - Gigoux, M. AU - Manem, V. S. K. AU - Bertos, N. AU - Zuo, D. AU - Perlitch, I. PY - 2019 DA - 2019// TI - Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers JO - J Clin Invest VL - 129 UR - https://doi.org/10.1172/JCI96313 DO - 10.1172/JCI96313 ID - Gruosso2019 ER -